Humoral and cellular response to a third booster dose SARS-CoV- 2 vaccination in patients with autoimmune disease: a case series

T Dimitroulas1 Fourth Department of Internal Medicine, Hippokration Hospital, School of Medicine, Thessaloniki, GreeceCorrespondence[email protected]

https://orcid.org/0000-0002-0364-1642 View further author information

A Tychala2 Department of Microbiology, Ahepa University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece

https://orcid.org/0000-0001-8471-9685 View further author information

E Katsimpourlia3 Department of Immunology, General Hospital G. Papanikolaou, Thessaloniki, Greece

https://orcid.org/0000-0003-0962-6942 View further author information

E Sidiropoulou2 Department of Microbiology, Ahepa University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece

https://orcid.org/0000-0001-9252-5688 View further author information

K Deuteraiou1 Fourth Department of Internal Medicine, Hippokration Hospital, School of Medicine, Thessaloniki, GreeceView further author information

M Papachristou4 Immunology Departments, National Peripheral Histocompatibility Center, Hippokration General Hospital of Thessaloniki, Thessaloniki, GreeceView further author information

A Fylaktou4 Immunology Departments, National Peripheral Histocompatibility Center, Hippokration General Hospital of Thessaloniki, Thessaloniki, GreeceView further author information

L Skoura2 Department of Microbiology, Ahepa University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece

https://orcid.org/0000-0001-9665-1286 View further author information

show all

References

Papagoras C, Fragoulis GE, Zioga N, Simopoulou T, Deftereou K, Kalavri E, et al. Better outcomes of COVID-19 in vaccinated compared to unvaccinated patients with systemic rheumatic diseases. Ann Rheum Dis. Published online: 10 Nov 2021. doi:10.1136/annrheumdis-2021-221539. Epub ahead of print.
Web of Science ®Google Scholar
Tzioufas AG, Bakasis AD, Goules AV, Bitzogli K, Cinoku II, Chatzis LG, et al. A prospective multicenter study assessing humoral immunogenicity and safety of the mRNA SARS-CoV-2 vaccines in Greek patients with systemic autoimmune and autoinflammatory rheumatic diseases. J Autoimmun 2021 Dec;125:102743.
PubMed Web of Science ®Google Scholar
Curtis JR, Johnson SR, Anthony DD, Arasaratnam RJ, Baden LR, Bass AR, et al. American College of Rheumatology guidance for COVID-19Vaccination in patients with rheumatic and musculoskeletal diseases: version 3. Arthritis Rheumatol 2021;73:e60–e75.
PubMed Web of Science ®Google Scholar
Connolly CM, Teles M, Frey S, Boyarsky BJ, Alejo JL, Werbel WA, et al. Booster-dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series. Ann Rheum Dis 2022;81:291–3.
PubMed Web of Science ®Google Scholar
Teles M, Connolly CM, Frey S, Chiang TP, Alejo JJ, Boyarsky BJ, et al. Attenuated response to fourth dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series. Ann Rheum Dis. Published online: 17 Jan 2022. doi:10.1136/annrheumdis-2021-221641. Epub ahead of print.
Web of Science ®Google Scholar
Connolly CM, Chiang TP, Boyarsky BJ, Massie A, Werbel WA, Shah AA, et al. Temporary hold of mycophenolate augments humoral response to SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases: a case series. Ann Rheum Dis 2022;81:293–5.
PubMed Web of Science ®Google Scholar
Furer V, Eviatar T, Zisman D, Peleg H, Peleg H, Paran D, et al. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study. Ann Rheum Dis 2021;80:1330–8.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Humoral and cellular response to a third booster dose SARS-CoV- 2 vaccination in patients with autoimmune disease: a case series

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Humoral and cellular response to a third booster dose SARS-CoV- 2 vaccination in patients with autoimmune disease: a case series

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date